Today marks a significant milestone for Western Balkans University, as we have officially finalized a Memorandum of Understanding with Cambridge Clinical Laboratories (CCL) to jointly establish and develop a new Biobank for biomedical research and clinical applications.
This strategic agreement was signed by Prof. Dr. Ferdinand Gjana, Rector of Western Balkans University, and Mr. Mehmet S. Dilmac, Administrator of Cambridge Clinical Laboratories. This partnership lays the foundation for a long-term collaboration dedicated to scientific excellence.
Strategic Objectives: The collaboration aims to transform the research landscape through:
- Advancing Innovation: Accelerating biomedical research and clinical discoveries.
- Infrastructure: Developing high-quality, state-of-the-art biobanking infrastructure.
- European Standards: Ensuring full compliance with EU regulations regarding quality, safety, ethics, and data protection.
- Interdisciplinary Growth: Strengthening the cooperation between academic study and clinical practice.
This partnership represents a major step toward fostering responsible research and international collaboration, positioning WBU at the forefront of medical science in the region.
